Le Lézard
Classified in: Health, Business
Subjects: TNM, AVO

Saga Nagoya Securities Comments on Allergan and Shire Pharmaceutical Acquisition


TOKYO, April 20, 2018 /PRNewswire/ - Saga Nagoya Securities has recently reported and commented on the pharmaceutical company Allergan Plc as they fell nearly 5 percent on Friday, posting the biggest ?intraday percentage loss in over five months after the company pulled out of talks to buy a ?controlling stake in the drugs company Shire.?

Allergan said in a filing to the U.K. regulators that it was engaged in ?negotiations to acquire Shire Plc, which has been recently at the center of a ?multibillion-dollar takeover battle.

Key research analysts at Saga Nagoya Securities said that the London-listed pharmaceutical company was ?on the radar of Japan's Takeda Pharmaceutical Co Ltd, but the board of ?Shire had rejected its latest $62 billion offer. The talks between the ?two parties.

"There has been a lot of mergers and acquisitions in recent years within the pharmaceutical industry not only in the United States but worldwide and it doesn't seem to be slowing down."? said Jonathan Richards, Corporate Trading at Saga Nagoya Securities.

Allergan has been ramping up its takeover ambitions as the company ?seeks growth overseas amid increased competition, pricing pressure, and ?patent challenges.

"The proposed ?deals significantly undervalue Shire's current assets and its future potentials." Highlighted Steven Phillips, Senior Vice President at Saga Nagoya Securities.

Analysts at Saga Nagoya Securities have stated that its key revenue drivers are failing ?to maintain momentum and will be prone to various pressures. ?

Japanese firm Takeda is now the sole public suitor after it has been eyeing controlling stake in ?Shire over the last few months. Takeda has already submitted three separate offers, but the board rejected them.

SOURCE Saga Nagoya Securities


These press releases may also interest you

at 09:05
Popular, Inc. announced today that it expects to report its financial results for the first quarter ending March 31, 2024, before the market opens on Tuesday, April 23, 2024. Popular will hold a conference call to discuss the financial results the...

at 09:05
Caliber (the "Company" or "CaliberCos Inc.") , a real estate investor, developer, and manager, today announced that it has rescheduled the release of its fourth quarter and full year 2023 financial results for before the open of the market on Monday,...

at 09:05
Pacific Premier Bancorp, Inc. ("Pacific Premier"), the holding company of Pacific Premier Bank, announced today that it will issue its first quarter 2024 financial results before the market opens on Wednesday, April 24, 2024. Pacific Premier will...

at 09:00
The Commerce Casino & Hotel, home to the largest poker room in the world, proudly announces an exciting partnership with the richest, most prestigious, and longest-running poker series ? the World Series of Poker® (WSOP®). This collaboration...

at 09:00
The Prelude Network® (Prelude), the largest network of fertility clinics in North America, announced today an expansion of its partnership with Labcorp , a global leader of innovative diagnostic and biopharma laboratory services, to serve as its...

at 09:00
GigaMedia Limited today announced its unaudited financial results for the fourth quarter and full year of 2023. Highlights For 2023, GigaMedia reported revenues of $4.3 million, with a gross profit of $2.4 million, an operating loss of $3.2 million...



News published on and distributed by: